<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Llata E</submitter><funding>Intramural CDC HHS</funding><pagination>777-779</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11334052</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>46(12)</volume><pubmed_abstract>We conducted a cross-sectional analysis using sexually transmitted disease clinic data to determine test of cure rates among persons diagnosed with pharyngeal gonococcal infections who were treated with a nonceftriaxone, nonazithromycin therapy. Less than 10% returned for a test of cure, highlighting the need to understand factors that can lead to improved compliance.</pubmed_abstract><journal>Sexually transmitted diseases</journal><pubmed_title>Pharyngeal Gonococcal Infections: A Cross-Sectional Study in a Network of Sexually Transmitted Disease Clinics; Sexually Transmitted Disease Surveillance Network-January 2016 to June 2018.</pubmed_title><pmcid>PMC11334052</pmcid><funding_grant_id>CC999999</funding_grant_id><pubmed_authors>Llata E</pubmed_authors><pubmed_authors>Kerani RP</pubmed_authors><pubmed_authors>Pathela P</pubmed_authors><pubmed_authors>Braxton J</pubmed_authors><pubmed_authors>Asbel L</pubmed_authors><pubmed_authors>Torrone E</pubmed_authors><pubmed_authors>Hsu K</pubmed_authors><pubmed_authors>Toevs K</pubmed_authors><pubmed_authors>Huspeni D</pubmed_authors><pubmed_authors>Schumacher C</pubmed_authors><pubmed_authors>Nguyen TQ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pharyngeal Gonococcal Infections: A Cross-Sectional Study in a Network of Sexually Transmitted Disease Clinics; Sexually Transmitted Disease Surveillance Network-January 2016 to June 2018.</name><description>We conducted a cross-sectional analysis using sexually transmitted disease clinic data to determine test of cure rates among persons diagnosed with pharyngeal gonococcal infections who were treated with a nonceftriaxone, nonazithromycin therapy. Less than 10% returned for a test of cure, highlighting the need to understand factors that can lead to improved compliance.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Dec</publication><modification>2025-04-26T21:17:06.31Z</modification><creation>2025-04-26T21:17:06.31Z</creation></dates><accession>S-EPMC11334052</accession><cross_references><pubmed>31764766</pubmed><doi>10.1097/OLQ.0000000000001073</doi><doi>10.1097/olq.0000000000001073</doi></cross_references></HashMap>